Biodexa Pharmaceuticals Plc Nasdaq

BDRX

US59564R8079

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 11:14:41 2026-03-17 am EDT			5-day change	1st Jan Change
0.7900 ^USD	-2.09%		-16.52%	-65.07%

Mar. 16	European Equities Traded in the US as American Depositary Receipts Higher Monday	MT
Mar. 13	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading	MT

Top Premarket Gainers

Published on 05/21/2024 at 07:40 am EDT - Modified on 05/21/2024 at 08:19 am EDT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Biodexa Pharmaceuticals Plc

Mar. 16	European Equities Traded in the US as American Depositary Receipts Higher Monday	MT
Mar. 13	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading	MT
Mar. 11	European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading	MT
Mar. 10	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT
Mar. 09	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT
Mar. 06	European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Down 5% for Week	MT
Mar. 04	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT
Feb. 26	European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading	MT
Feb. 24	European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading	MT
Feb. 20	European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday trading	MT
Feb. 19	European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	MT
Feb. 17	European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Tuesday Trading	MT
Feb. 12	European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	MT
Feb. 10	European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading	MT
Feb. 09	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT

Chart Biodexa Pharmaceuticals Plc

Duration

Period

BDRX: Dynamic Chart

Biodexa Pharmaceuticals PLC is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. The Q-Sphera technology focuses on long-acting injectables using proprietary three-dimensional (3D) printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. The MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. The MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility biological potential of Hydrogen (pH), extending available routes of administration, including direct-to-tumor delivery. Its pipeline includes MTX110, MTD201, MTD211 (Schizophrenia, MDD), MTX223, and MTD217.

Employees

Sector

Biotechnology & Medical Research

More about the company